Sponsor:
Columbia University
Code:
NCT06042699
Conditions
Adolescent Idiopathic Scoliosis
Neuromuscular Scoliosis
Perioperative/Postoperative Complications
Iron Deficiencies
Anemia
Eligibility Criteria
Sex: All
Age: 10 - 26
Healthy Volunteers: Accepted
Interventions
Oral ferrous sulfate
Oral placebo tablet
Brief summary:
Conditions
Adolescent Idiopathic Scoliosis
Neuromuscular Scoliosis
Perioperative/Postoperative Complications
Iron Deficiencies
Anemia
Study ID
NCT06042699
Start date
Jan 11, 2024
Status verified date
Jun, 2026
Completion date
Feb 1, 2028
Anticipated
Primary completion date
Dec 15, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 10 - 26
Healthy Volunteers: Accepted
Enrollment
275 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Oral ferrous sulfate
placebo comparator: Oral placebo tablets
no intervention: Observational follow-up
Interventions
Oral ferrous sulfate
Oral placebo tablet
Primary outcome measure
Central contacts
Locations
Columbia University Medical Center
Recruiting
New York, New York, United States, 10032
Contacts
Lisa Eisler, MD
ldl2113@cumc.columbia.eduPrincipal Investigator:
Lisa Eisler, MD
Sponsor
Columbia University
Last update posted
Jun 26, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Columbia University on 2026-06-26.